Cinctive Capital Management LP Becton Dickinson & CO Transaction History

Cinctive Capital Management LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$225.07 - $246.17 $4.13 Million - $4.51 Million	18,330 Added 635.8%	21,213 $4.96 Million
Q1 2024 May 15, 2024	SELL	$233.45 - $247.73 $2.37 Million - $2.52 Million	-10,165 Reduced 77.9%	2,883 $713,000
Q4 2023 Feb 14, 2024	SELL	$232.24 - $267.23 $7.12 Million - $8.19 Million	-30,657 Reduced 70.15%	13,048 $3.18 Million
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $1.83 Million - $2.03 Million	7,173 Added 19.63%	43,705 $11.3 Million
Q2 2023 Aug 14, 2023	SELL	$238.39 - $265.32 $3.8 Million - $4.23 Million	-15,945 Reduced 30.38%	36,532 $9.64 Million
Q1 2023 May 15, 2023	BUY	$229.71 - $259.35 $12.1 Million - $13.6 Million	52,477 New	52,477 $13 Million
Q2 2022 Aug 15, 2022	BUY	$234.74 - $275.42 $7.68 Million - $9.01 Million	32,701 New	32,701 $8.06 Million
Q1 2020 May 15, 2020	SELL	$195.69 - $279.01 $4.46 Million - $6.36 Million	-22,801 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$236.45 - $266.82 $5.39 Million - $6.08 Million	22,801 New	22,801 $6.2 Million

1,738

249M

690K

787K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.2B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Cinctive Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Cinctive Capital Management LP with notifications on news.